Under a new medicare program to expand coordinated care forvulnerable seniors, insurers and managed care plans across thecountry are offering a range of Special Needs Plans (SNPs, or"snips") to beneficiaries who are dual eligibles, in nursing homesor suffer from chronic conditions. Most of the 275 SNPs approved bythe Medicare program so far aim to provide care to low-incomeseniors who now receive prescription drug benefits from Medicareinstead of state Medicaid programs; special needs plans for othergroups are emerging slowly.
Under a new medicare program to expand coordinated care for vulnerable seniors, insurers and managed care plans across the country are offering a range of Special Needs Plans (SNPs, or "snips") to beneficiaries who are dual eligibles, in nursing homes or suffer from chronic conditions. Most of the 275 SNPs approved by the Medicare program so far aim to provide care to low-income seniors who now receive prescription drug benefits from Medicare instead of state Medicaid programs; special needs plans for other groups are emerging slowly.
For the Centers for Medicare and Medicaid Services (CMS), the program provides an opportunity to better coordinate federal and state coverage for vulnerable populations. The hope is that SNPs will be able to provide higher quality of care to these patients at lower costs.
RAPID GROWTH
As a result, almost 60% of all Medicare beneficiaries now live in areas served by some kind of SNP. Most are clustered in more populated regions, while eight states have only one SNP. Florida has 14 SNP contracts, followed by New York, Minnesota, California, Arizona and Texas. Although only 65,000 Medicare beneficiaries were enrolled in SNPs last year, the number now is much higher and is projected to grow as additional SNPs gain approval.
The market response "is much stronger than anyone anticipated when the measure was drafted," says John Blum, analyst with Avalere Health. The Medicare legislation aimed to provide an umbrella for several smaller demonstrations and other special programs. Insurers have seized the program as a way to broaden their market by integrating services for dual eligibles, as well as for institutionalized and vulnerable populations, Blum says. And some plans are offering "niche products" that provide services to seniors with HIV/AIDS or mental health conditions.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More